H16.053
Mooren's corneal ulcer, bilateral
Clinical Classification Guidelines
Medical Intelligence & Overview
Mooren's corneal ulcer, bilateral, is a rare, aggressive form of ulcerative keratitis that affects both eyes. It involves progressive destruction of the corneal tissue without an apparent infectious cause. Understanding this condition is essential for early recognition and management to prevent potential vision loss. The ICD-10 code H16.053 categorizes this specific diagnosis, emphasizing its bilateral nature—meaning it occurs in both eyes simultaneously or sequentially.
Causes & Symptoms
Clinical Causes: Autoimmune response: The exact cause is unknown, but it is believed to involve an abnormal immune reaction targeting the cornea. Genetic predisposition: Some cases may have a familial component or genetic susceptibility, although specific genes are not well defined. Environmental factors: Possible triggers include trauma or exposure to environmental irritants that may initiate immune responses. Other autoimmune conditions: Individuals with systemic autoimmune diseases such as rheumatoid arthritis or lupus may have an increased risk.
Key Symptoms: Gradual loss of vision in affected eyes Severe eye pain or discomfort Redness and swelling of the eye Photophobia — sensitivity to light Tearing and discharge from the eyes Decreased corneal transparency or haziness Progressive corneal thinning leading to potential perforation
Diagnostic & Treatment
Diagnosis Path: Slit-lamp examination: To assess the extent of corneal ulceration and tissue destruction Corneal scraping and laboratory tests: To rule out infectious causes such as bacterial, viral, or fungal infections Histopathological analysis: When necessary, to examine tissue biopsies for characteristic autoimmune features Imaging studies: Anterior segment optical coherence tomography (OCT) may help evaluate corneal thickness and structure Exclusion of other conditions: Differential diagnoses include peripheral ulcerative keratitis associated with systemic autoimmune diseases, which require careful assessment
Treatment Protocols: Immunosuppressive therapy: Topical corticosteroids, systemic immunosuppressants (like cyclosporine or azathioprine), or other agents to reduce immune activity Cycloplegic agents: To relieve pain and prevent synechiae formation Antibiotic or antifungal medications: If secondary infection complicates the ulcer Surgical procedures: Such as conjunctival resection, lamellar keratoplasty, or full-thickness corneal transplant in advanced cases Close monitoring: Regular follow-up with an ophthalmologist to assess treatment response and detect complications early Supportive care: Use of lubricating eye drops and protective measures to minimize trauma
Clinical Advice & FAQs
Billing Guidance
Is H16.053 a billable ICD-10 code?
Yes, H16.053 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H16.053?
Clinical documentation must specify the nature of Mooren's corneal ulcer, bilateral and any associated comorbidities for accurate reporting.
Cite this Clinical Reference